Clinical Trials Directory

Trials / Unknown

UnknownNCT02890108

Effect of Consumption of Non Caloric Sweeteners and Insulin Sensibility

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Instituto de Nutrición y Tecnología de los Alimentos · Academic / Other
Sex
All
Age
25 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study will compare the effect of acute consumption of two carbonated drinks, sweetened with sugar or with non-caloric sweeteners, over the insulin response of healthy adults who normally consumed foods or drinks that contain non-caloric sweeteners

Detailed description

During the last decades there has been a sustained increase in prevalence of overweight and obesity and, along with it, of chronic noncommunicable diseases. There have been addressed various management strategies, including sugar replacement for Non-caloric Artificial Sweeteners (NAS). Nevertheless, in several cohort studies it has found the opposite effect, it has observed associations between the consumption of NAS with greater weight gain and increased risk of type 2 diabetes and metabolic syndrome. In clinical trials, in both humans and mice, there has been greater association with glucose intolerance, being 3 possible mechanisms: 1) dysbiosis of the intestinal microbiota; 2) altered regulation of appetite cephalic phase and secretion of glucagon like peptide-1 (GLP-1); and 3) increased intestinal glucose absorption via increased Sodium-Glucose Linked Transporter-1 (SGLT-1) and Glucose transporter 2 (GLUT2), transporters to glucose absorption. In the following review the major findings in the literature regarding the consumption of NAS and its deleterious effects on human health will be studied.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSugar sweetened beverages350 cc (1 can) of sugar sweetened beverage
DIETARY_SUPPLEMENTArtificially sweetened beverages350 cc (1 can) of artificially sweetened beverage

Timeline

Start date
2016-08-01
Primary completion
2016-09-01
Completion
2016-10-01
First posted
2016-09-07
Last updated
2016-09-07

Locations

1 site across 1 country: Chile

Source: ClinicalTrials.gov record NCT02890108. Inclusion in this directory is not an endorsement.